When was PeriVision founded?

PeriVision was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is PeriVision located?

PeriVision is headquartered in Epalinges, Switzerland. It is registered at Route de la Corniche 3, 1066 Epalinges, CH.

How many employees does PeriVision have?

As of Aug 31, 2026, the latest employee count at PeriVision is 10.

Is PeriVision a funded company?

PeriVision is a funded company, having raised a total of $4.69M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Feb 11, 2020.

When was the latest funding round of PeriVision?

PeriVision's latest funding was a $***** Seed round on Sep 16, 2025, with participation from 8 investors.

Where does PeriVision rank among its competitors?

PeriVision ranks 3rd amongst 45 active competitors, of which 17 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was PeriVision, which secured $3M in Sep, 2025.

Who are the top competitors of PeriVision?

PeriVision's top competitors include Remidio, Intelligent Retinal Imaging Systems and Heru. Among them, PeriVision secured the most recent funding round in September, 2025.

PeriVision - 2026 Company Profile, Team, Funding & Competitors

PeriVision is a seed company based in Epalinges (Switzerland), founded in 2019 by Patrick Kessel. It operates as a SaaS and AI based vision care clinical workflow for professionals and patients. PeriVision has raised $4.69M in funding from investors like Arya Women, Founders Network and Biopole. The company has 45 active competitors, including 17 funded and 1 that has exited. Its top competitors include companies like Remidio, Intelligent Retinal Imaging Systems and Heru.

Company Details

SaaS and AI based vision care clinical workflow for professionals and patients. It provides VR visual field testing platform for eye care. It uses virtual reality headsets and cloud computing to diagnose and monitor eye diseases, such as glaucoma. AI algorithms optimize tests, automate assistance, and provide insights for clinical decisions. The technology is validated through clinical studies and published research. The platform facilitates at home vision testing, enhancing patient access and streamlining clinical trials.

Website: www.perivision.com/
Social
Registered Address: Route de la Corniche 3, 1066 Epalinges, CH

Key Metrics

Founded Year

2019

Location

Epalinges, Switzerland

Stage

Seed

Total Funding

$4.69M in 7 rounds

Latest Funding Round

Seed, Sep 16, 2025, $*****

Investors

Arya Women & 12 more

Ranked

3^rd among 45 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

Remidio & 48 more

View PeriVision's full profile

PeriVision is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PeriVision SA CIN: 1528855 , Switzerland, Active	Feb 09, 2023	-	-	-

PeriVision has raised a total funding of $4.69M over 7 rounds. Its first funding round was on Feb 11, 2020. Its latest funding round was a Seed round on Sep 16, 2025 for $*****. 8 investors participated in its latest round. PeriVision has 13 institutional investors.

Here is the list of recent funding rounds of PeriVision:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 16, 2025	9761023	Seed	2364297	5011607	9670607	3573341
Oct 01, 2024	5873373	Grant (prize money)	5092959	6627538	6045341	8250900
Jul 27, 2023	3027440	Seed	2158210	8497414	Swiss ICT Investor Club & 3 more	FIT

Access funding benchmarks and valuations. Sign up today!

View details of PeriVision's funding rounds and investors

The founders of PeriVision is Patrick Kessel.

Here are the details of PeriVision's key team members:

Patrick Kessel: Founder of PeriVision.
Contact Info: 1 email address

View details of PeriVision's Founder profiles and Board Members

PeriVision's employee count trend

PeriVision has 10 employees as of Aug 26. Here is PeriVision's employee count trend over the years:

Uncover PeriVision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PeriVision include Remidio, Intelligent Retinal Imaging Systems and Heru. Here is the list of Top 10 competitors of PeriVision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Remidio 2009, Bengaluru (India), Series B	Developer of AI-powered portable digital solutions for ophthalmic screening and diagnosis	$25M	Montane Ventures, KITVEN & 32 others	66/100
2nd	Intelligent Retinal Imaging Systems 2011, Pensacola (United States), Acquired	Telemedicine system for the early detection of diabetic eye disease	$13.3M	Ballast Point Ventures, Allumia Ventures & 1 others	60/100
3rd	PeriVision 2019, Epalinges (Switzerland), Seed	SaaS and AI based vision care clinical workflow for professionals and patients	$4.69M	Zühlke, Venture Kick & 11 others	57/100
4th	Heru 2018, Miami (United States), Series A	AI-based medical vision diagnostic device and platform	$36.7M	Open Opportunity Fund, Krillion Ventures & 3 others	55/100
5th	Optain 2023, New York City (United States), Series A	AI-powered retinal imaging technology for non-invasive evaluation of patients	$38M	Insight Partners, Lumio Capital & 8 others	55/100
6th	AIOptics 2020, New York (United States), Series B	Provider of AI-based digital platform and device to prevent blindness	$14.7M	Octane, HHS	49/100
7th	Topconhealthcare 2018, Oakland (United States), Unfunded	-	-	-	47/100
8th	Oivi 2017, Oslo (Norway), Seed	Online platform for tracking eye diseases through teleconsultation	$500K	Arali Ventures, Forward Slash & 5 others	46/100
9th	Artelus 2015, Bengaluru (India), Seed	AI based platform for medical diagnosis	$521K	L V Prasad Eye Institute	44/100
10th	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Trousdale Ventures, Skyview Ventures & 1 others	42/100